27


Figure 1.  APSR congress was held in Sydney International Convention Centre (ICC).


Congress of Asian Pacific Society of Respirology (APSR) is an event that focusing on respirology disease, including asthma, tuberculosis, and lung cancer. This event was held on 23rd - 26th, November 2017 and was hosted by Thoracic Society of Australia and New Zealand in partnership with APSR.

This year, APSR congress took place in Sydney, the state capital of New South Wales, located on Australia’s east coast. This four days event consisted of pre-congress workshop, plenary lectures, major symposia, oral presentation, and poster presentation, making this event become a wonderful educational experience for the attendees.

“This year promises to be yet another superb Congress, not only because of its unique location in Sydney, but also because of the amazing work the local Thoraic Society of Australia and New Zealand team have undertaken to ensure the highest quality scientific and educational program”, Prof. Kwun Fong, President of the APSR stated in his welcome message.

Lung cancer has been one of SCI main research interest since several years ago. Our study has been mainly focusing on prognostics and predictive factor of lung cancer biomarker in Indonesian patients. In this APSR event, we were honoured to be invited as oral presenter and shared the results of our study in lung cancer.




Figure 2.  Mr. Ahmad R. Utomo,PhD and 
Najmiatul Masykura presented cancer research in APSR congress.

Mr. Ahmad R. Utomo, Ph.D., delivered a presentation entitled Common and Uncommon EGFR Mutations Analysis in Cytology and Plasma samples of Treatment-Naive Lung Cancer Patients, and explained the correlation of EGFR gene mutation and lung cancer patients survival. In the other presentation, entitled KRAS Mutation in EGFR Wild Type Indonesian Lung Cancer Patients, Najmiatul Masykura talked about KRAS mutation in Lung Cancer Patients and its correlation with smoking history.

We were also delighted to meet the other researchers as well as clinicians that is working on the same interest through this event. Lung cancer remains as one of the top cause of cancer related death in the world. We are fully aware that, continuous study of lung cancer is an important task that should be shouldered by several parties, including clinician, researcher, and government.



Figure 3.  Mr. Ahmad R. Utomo, Ph.D (principal investigator at SCI) with Fariz Nurwidya, MD, Ph.D (left)
and dr. Sita Andarini, Ph.D, Sp.P (K) at APSR event.


Figure 3.  Mr. Ahmad R. Utomo, phD (principal investigator at SCI) with Fariz Nurwidya, MD, PhD (left) and dr. Sita Andarini, PhD, SpP (K) at APSR event.


Figure 3.  Mr. Ahmad R. Utomo, phD (principal investigator at SCI) with Fariz Nurwidya, MD, PhD (left) and dr. Sita Andarini, PhD, SpP (K) at APSR event.



Figure 4.  SCI team were discussing about EGFR, KRAS and PDL-1 in lung cancer with researcher from Japan National Cancer Center.



Post Rating

Comments

There are currently no comments, be the first to post one.

Post Comment

Only registered users may post comments.

News & Events

SCAN

Events

SCI - Events

Stem Cell News

Cell Therapy News

Cancer News